Evaluation of a double-target therapeutic in preclinical models of Parkinson's disease

被引：0
|
作者：
Sanz, F. J.
Solana-Manrique, C.
Masia, E.
Vicent, M. J.
Paricio, N.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
532
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [1] Neurotoxins as Preclinical Models for Parkinson's Disease
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2018, 34 (04) : 870 - 877
  • [2] Neurotoxins as Preclinical Models for Parkinson’s Disease
    Juan Segura-Aguilar
    Neurotoxicity Research, 2018, 34 : 870 - 877
  • [3] PPAR: a therapeutic target in Parkinson's disease
    Chaturvedi, Rajnish K.
    Beal, M. Flint
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (02) : 506 - 518
  • [4] Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo, Yu
    Hoffer, Alan
    Hoffer, Barry
    Qi, Xin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09) : 20704 - 20730
  • [5] Iron as a therapeutic target for Parkinson's disease
    Moreau, Caroline
    Duce, James A.
    Rascol, Olivier
    Devedjian, Jean-Christophe
    Berg, Daniela
    Dexter, David
    Cabantchik, Z. Ioav
    Bush, Ashley I.
    Devos, David
    MOVEMENT DISORDERS, 2018, 33 (04) : 568 - 574
  • [6] α-Synuclein: A therapeutic target for Parkinson's disease?
    Maguire-Zeiss, Kathleen A.
    PHARMACOLOGICAL RESEARCH, 2008, 58 (5-6) : 271 - 280
  • [7] The Epigenome as a therapeutic target for Parkinson’s disease
    Shane V.Hegarty
    Aideen M.Sullivan
    Gerard W.O’Keeffe
    Neural Regeneration Research, 2016, (11) : 1735 - 1738
  • [8] Glucocerebrosidase as a therapeutic target for Parkinson's disease
    Chen, Yu
    Sam, Richard
    Sharma, Pankaj
    Chen, Lu
    Do, Jenny
    Sidransky, Ellen
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (04) : 287 - 294
  • [9] The Epigenome as a therapeutic target for Parkinson's disease
    Hegarty, Shane V.
    Sullivan, Aideen M.
    O'Keeffe, Gerard W.
    NEURAL REGENERATION RESEARCH, 2016, 11 (11) : 1735 - 1738
  • [10] Glycolysis as a therapeutic target for Parkinson's disease
    Foltynie, Thomas
    LANCET NEUROLOGY, 2019, 18 (12): : 1072 - 1074
12345